Segregated Portfolio Cell Reinsurance
Search documents
ProAssurance Q3 Earnings Miss Estimates on Weak Specialty P&C Unit
ZACKS· 2025-11-07 19:21
Core Insights - ProAssurance Corporation (PRA) reported weaker third-quarter 2025 results, with shares dipping marginally due to poor underwriting performance, declining gross premiums written, and elevated expenses [1][2][5] - The company experienced a significant drop in adjusted operating income and net income, while investment income showed strong growth [2][4][9] Financial Performance - Adjusted operating income was 15 cents per share, missing the Zacks Consensus Estimate by 46.4% and down 53.1% year over year [2][9] - Operating revenues totaled $274 million, a decrease of 1.4% year over year, and missed the consensus mark by 0.7% [2] - Gross premiums written fell 5.7% year over year to $290.4 million, below the estimate of $301.9 million [3][9] - Net premiums earned decreased 4% year over year to $233.4 million, surpassing the Zacks Consensus Estimate but missing the internal estimate [3] Investment Income and Expenses - Net investment income increased 8.5% year over year to $40.4 million, exceeding both the consensus and internal estimates [4] - Total expenses rose 4.2% year over year to $275.2 million, driven by higher net losses and operating costs, surpassing internal estimates [4] Segment Performance - Specialty P&C Segment revenues declined 4.4% year over year to $181.8 million, missing estimates [6] - Workers' Compensation Insurance Segment revenues fell 2.3% year over year to $41.4 million, also missing estimates [8] - Segregated Portfolio Cell Reinsurance Segment saw gross premiums written improve 4.2% year over year to $14.2 million, with a profit increase of 66.5% [11][12] Financial Position - As of September 30, 2025, cash and cash equivalents were $54.5 million, down 0.8% from the end of 2024 [14] - Total investments reached $4.4 billion, up 1.6% from the previous year [14] - Total shareholders' equity increased 8.5% to $1.3 billion, with book value per share growing 8% to $25.37 [15] Share Repurchase Update - ProAssurance did not repurchase any common shares in the third quarter of 2025, with a remaining capacity of $55.9 million for future repurchases or debt retirement [16]
ProAssurance (PRA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-08-06 01:01
Core Insights - ProAssurance reported a revenue of $271.94 million for the quarter ended June 2025, reflecting a decrease of 2.4% year-over-year, but exceeding the Zacks Consensus Estimate by 1.96% [1] - The company's EPS was $0.52, significantly higher than the $0.23 reported in the same quarter last year, resulting in an EPS surprise of 173.68% compared to the consensus estimate of $0.19 [1] Financial Performance Metrics - Net Loss Ratio was reported at 68.8%, better than the average estimate of 77% from three analysts [4] - Underwriting Expense Ratio stood at 34.8%, slightly above the average estimate of 33.9% [4] - Combined Ratio was 103.6%, outperforming the average estimate of 110.9% [4] - Net premiums earned totaled $232.41 million, surpassing the average estimate of $225.22 million, but showing a year-over-year decline of 3.1% [4] - Net investment income was $38.93 million, exceeding the average estimate of $37.5 million, with a year-over-year increase of 6.5% [4] - Equity in earnings of unconsolidated subsidiaries was $4.58 million, compared to the average estimate of $3.07 million, reflecting a 47% decrease year-over-year [4] - Other income was reported at $0.6 million, significantly lower than the average estimate of $2.68 million, marking a 71.5% decline year-over-year [4] Segment Performance - Net Premiums Earned in Specialty Property & Casualty was $179.31 million, slightly below the average estimate of $180.34 million, with a year-over-year decrease of 2.8% [4] - Net Premiums Earned in Segregated Portfolio Cell Reinsurance was $11.56 million, compared to the average estimate of $12.1 million, reflecting a 14.7% year-over-year decline [4] - Net Premiums Earned in Workers Compensation was $41.54 million, close to the average estimate of $41.61 million, showing a minor decrease of 0.5% year-over-year [4] - Net investment income in Segregated Portfolio Cell Reinsurance was $0.9 million, slightly below the average estimate of $0.91 million, with an 8.4% year-over-year decline [4] Stock Performance - ProAssurance shares returned +0.6% over the past month, underperforming the Zacks S&P 500 composite's +1% change [3] - The stock currently holds a Zacks Rank 5 (Strong Sell), indicating potential underperformance in the near term [3]